Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

13.55
Delayed Data
As of Aug 21
 +2.45 / +22.07%
Today’s Change
10.80
Today|||52-Week Range
31.98
-51.87%
Year-to-Date
No recent news for Coherus BioSciences Inc.

Today’s Trading

Previous close11.10
Today’s open11.30
Day’s range11.30 - 13.80
Volume1,337,530
Average volume (3 months)746,261
Market cap$570.0M
Dividend yield--
Data as of 3:59pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)+49.42%
Earnings growth (this year)-37.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+532.82%
P/E ratioNM
Price/Sales6.21
Price/Book24.77

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...+1.59+10.49%
IMGNImmunoGen Inc+0.25+4.16%
ANIPANI Pharmaceuticals ...-0.14-0.30%
AMAGAMAG Pharmaceuticals...+0.45+2.62%
Data as of 4:00pm ET, 08/21/2017

Financials

Next reporting dateDecember 18, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$190.1M
Annual profit (last year)-$127.3M
Net profit margin-66.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts